Lymphangioleiomyomatosis

Chest

Volumn 114, Issue 6, 1998, Pages 1689-1703

  Sullivan, Eugene J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angiomyolipoma; Interstitial lung disease; Lymphangioleiomyomatosis; Tuberous sclerosis complex

Indexed keywords

HUMAN; LUNG; LUNG TUMOR; LYMPHANGIOLEIOMYOMATOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

HUMANS; LUNG; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; PROGNOSIS;

EID: 0032246307     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1689     Document Type: Review

References (124)

1. Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis: a review. Am J Pathol 1975; 79:348-367
2. Sieker OH, McCarty KS. Lymphangiomyomatosis: a respiratory illness with an endocrinologic therapy. Trans Am Clin Climatol Assoc 1987; 99:57-67
3. Taylor JR, Ryu J, Colby TV, et al Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990; 323:1254-1260
4. Kitaichi M, Nishimura K, Itoh H, et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151:527-533
5. Castro M, Shepherd CW, Gomez MR, et al. Pulmonary tuberous sclerosis. Chest 1995; 107:189-195
6. Cornog JL, Enterline HT. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma. Cancer 1966; 19:1909-1930
7. Laipply TC, Sherrick JC. Intrathoracic angiomyomatous hyperplasia associated with chronic chylothorax. Lab Invest 1958; 7:387-400
8. Uzzo RG, Libby DM, Vaughan ED Jr, et al. Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. J Urol 1994; 151:1612-1615
9. Dwyer JM, Hickie JB, Garvan J. Pulmonary tuberous sclerosis: report of three patients and a review of the literature. Q J Med 1971; 40:115-125
10. Lie JT, Miller RD, Williams DE. Cystic disease of the lungs in tuberous sclerosis: clinicopathologic correlation, including body plethysmographic lung function tests. Mayo Clin Proc 1980; 55:547-553
11. Lutembacher R. Dysembryomes metatypique des reins: carcinose submiliaire aigue du poumon avec emphyseme generalise et double pneumothorax. Ann Med 1918; 5:435-450
12. Berg G, Vejlens G. Maladie kystique du poumon et sclerose tubereuse du cerveau. Acta Paediatr (Uppsala) 1939; 26: 16-30
13. Valensi QJ. Pulmonary lymphangiomyoma, a probable forme frust of tuberous sclerosis: a case report and survey of the literature. Am Rev Respir Dis 1973; 108:1411-1415
14. Kaku T, Toyoshima S, Enjoji M. Tuberous sclerosis with pulmonary and lymph node involvement: relationship to lymphangiomyomatosis. Acta Pathol Jpn 1983; 33:395-401
15. Capron F, Ameille J, Leclerc P, et al. Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: the same disease? Cancer 1983; 52:851-855
16. Hauck RW, Konig G, Permanetter W, et al. Tuberous sclerosis with pulmonary involvement. Respiration 1990; 57:289-292
17. Peng SF, Chang YC, Su CT, et al. High-resolution computed tomography in pulmonary lymphangio(leio)myomatosis and pulmonary tuberous sclerosis. J Formos Med Assoc 1996; 95:399-402
18. Torres VE, Bjornsson J, King BF, et al. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc 1995; 70:641-648
19. Vadas G, Pare JAP, Thurlbeck WM. Pulmonary and lymph node myomatosis: review of the literature and report of a case. Can Med Assoc J 1967; 96:420-424
20. Monteforte WJ, Kohnen PW. Angiomyolipomas in a case of lymphangiomyomatosis syndrome: relationships to tuberous sclerosis. Cancer 1974; 34:317-321
21. Kerr LA, Blute ML, Ryu JH, et al. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis: forme fruste of tuberous sclerosis? Urology 1993; 41:440-444
22. Maziak DE, Kesten S, Rappaport DC, et al. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J 1996; 9:402-405
23. Gomez MR. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci 1991; 615:1-7
24. Bonetti F, Chiodera P. Lymphangioleiomyomatosis and tuberous sclerosis: where is the border? [editorial]. Eur Respir J 1996; 9:399-401
25. Wolff M. Lymphangiomyoma: clinicopathologic study and ultrastructural confirmation of its histogenesis. Cancer 1973; 31:988-1007
26. Pachter MR, Lattes R. Mesenchymal tumors of the mediastinum: tumors of lymph vascular origin. Cancer 1963; 16:108-117
27. Awai K, Fujikawa K, Sato T, et al. Pulmonary lymphangiomyomatosis. Radiat Med 1990; 8:132-135
28. Joliat G, Stalder H, Kapanci Y. Lymphangiomyomatosis: a clinico-anatomical entity. Cancer 1973; 31:455-461
29. Sinclair W, Wright JL, Churg A. Lymphangioleiomyomatosis presenting in a postmenopausal woman. Thorax 1985; 40:475-476
30. Baldi S, Papotti M, Valente ML, et al. Pulmonary lymphangioleiomyomatosis in postmenopausal women: report of two cases and review of the literature. Eur Respir J 1994; 7:1013-1016
31. Zanella A, Toppan P, Nitti D, et al. Pulmonary lymphangioleiomyomatosis: a case report in postmenopausal women treated with pleurodesis and progesterone (medroxyprogesterone acetate). Tumori 1996; 82:96-98
32. Bush JK, McLean RL, Sieker HO. Diffuse lung disease due to lymphangiomyoma. Am J Med 1969; 46:645-654
33. Graham ML, Spelsberg TC, Dines DE, et al. Pulmonary lymphangiomyomatosis: with particular reference to steroid-receptor assay studies and pathologic correlation. Mayo Clin Proc 1984; 59:3-11
34. Guinee D, Singh R, Azumi N, et al. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod Pathol 1995; 8:902-906
35. Berkman N, Bloom A, Cohen P, et al. Bilateral spontaneous pneumothorax as the presenting feature in lymphangioleiomyomatosis [see comments]. Respir Med 1995; 89:381-383
36. Lantuejoul S, Ferretti G, Negoescu A, et al. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis. Histopathology 1997; 30:570-575
37. Flieder DB, Travis WD. Clear cell 'sugar tumor' of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol 1997; 21:1242-1247
38. Kane PB, Lane BP, Cordice JWV, et al. Ultrastructure of the proliferating cells in pulmonary lymphangiomyomatosis. Arch Pathol Lab Med 1978; 102:618-622
39. Schiaffino E, Tavani E, Dellafiore L, et al. Pulmonary lymphangiomyomatosis: report of a case with immunohistochemical and ultrastructural findings. Appl Pathol 1989; 7:265-272
40. Adamson D, Heinrichs WL, Raybin DM, et al. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis 1985; 132: 916-921
41. Brock ET, Votto JJ. Lymphangioleiomyomatosis: treatment with hormonal manipulation. NY State J Med 1986; 86:533-536
42. van Milligen de Wit AW, Meilof-Planteydt MN. Successful treatment of pulmonary lymphangioleiomyomatosis with oophorectomy and medroxyprogesterone-acetate: report of a case and brief review of the literature. Neth J Med 1990; 36:246-251
43. Stovin PGI, Lum LC, Flower CDR, et al. The lungs in lymphangiomyomatosis and in tuberous sclerosis. Thorax 1975; 30:497-509
44. Abe R, Kimura M, Airosaki A, et al. Retroperitoneal lymphangiomyomatosis with lymphedema of the legs. Lymphology 1980; 13:62-67
45. Kanbe A, Hajiro K, Adachi Y, et al. Lymphangiomyomatosis associated with chylous ascites and high serum CA-125 levels: a case report. Jpn J Med 1987; 26:237-242
46. Calvo E, Amarillas L, Mateos MA, et al. Lymphangioleiomyomatosis, chylous ascites, and diet. Dig Dis Sci 1996; 41:591-593
47. Calabrese PR, Frank HD, Taubin HL. Lymphangiomyomatosis with chylous ascites: treatment with dietary fat restriction and medium chain triglycerides. Cancer 1977; 40:895-897
48. Crausman RS, Mellman D, Bloomfield EC, et al. Pulmonary barotrauma as the cause of pneumoretropharynx in pulmonary lymphangioleiomyomatosis. Am J Emerg Med 1996; 14:297-299
49. Carrington CB, Cugell DW, Gaensler EA, et al Lymphangioleiomyomatosis: physiologic pathologic radiologic correlations. Am Rev Respir Dis 1977; 116:977-995
50. Kawahara Y, Taniguchi T, Kadou T, et al. Elevated pulmonary arterial pressure in pulmonary lymphangiomyomatosis. Jpn J Med 1989; 28:520-522
51. Lieberman J, Nosal A, Schlessner LA, et al. Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis 1979; 120:329-335
52. El Allaf D, Borlee G, Hadjoudj H, et al. Pulmonary lymphangiomyomatosis. Eur J Respir Dis 1984; 65:147-152
53. Radermecker M, Broux R, Corhay J-L, et al. Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients. Chest 1992; 101: 1724-1726
54. McCarty KS, Mossler JA, McLelland R, et al. Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med 1980; 303:1461-1465
55. Hughes E, Hodder RV. Pulmonary lymphangiomyomatosis complicating pregnancy: a case report. J Reprod Med 1987; 32:553-557
56. Yockey CC, Riepe RE, Ryan K. Pulmonary lymphangioleiomyomatosis complicated by pregnancy. Kans Med 1986; 87:277-278, 293
57. Sleiman C, Mal H, Jebrak G, et al. Pulmonary lymphangiomyomatosis treated by single lung transplantation. Am Rev Respir Dis 1992; 145:964-966
58. Eliasson AH, Phillips YY, Tenholder MF. Treatment of lymphangioleiomyomatosis: a meta-analysis. Chest 1989; 96:1352-1355
59. Urban T, Kuttenn F, Gompel A, et al. Pulmonary lymphangiomyomatosis: follow-up and long-term outcome with antiestrogen therapy: a report of eight cases. Chest 1992; 102:472-476
60. Brunelli A, Catalini G, Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet 1996; 52:289-290
61. Kreisman H, Robitaille Y, Dionne GP, et al. Lymphangiomyomatosis syndrome with hyperparathyroidism: a case report. Cancer 1978; 42:364-372
62. Shen A, Iseman MD, Waldron JA, et al. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 1987; 91:782-785
63. Silverstein EF, Ellis K, Wolff M, et al. Pulmonary lymphangiomyomatosis. AJR Am J Roentgenol 1974; 120:832-850
64. Basset F, Soler P, Marsac J, et al. Pulmonary lymphangiomyomatosis: three new cases studied with electron microscopy. Cancer 1976; 38:2357-2366
65. Kitzsteiner KA, Mallen RG. Pulmonary lymphangiomyomatosis: treatment with castration. Cancer 1980; 46:2248-2249
66. Banner AS, Carrington CB, Emory WB, et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981; 305:204-209
67. Svendsen TL, Viskum K, Hansborg N, et al. Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 1984; 78:264-271
68. Wahedna I, Cooper S, Williams J, et al. Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study. Thorax 1994; 49:910-914
69. Blute ML, Malek RS, Segura JW. Angiomyolipoma: clinical metamorphosis and concepts for management. J Urol 1988; 139:20-24
70. Bernstein SM, Newell JD Jr, Adamczyk D, et al. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med 1995; 152:2138-2143
71. Conrad S, Wagner B, Hamper K, et al. Nierenkarzinom und angiomyolipom bei lymphangiomyomatose [Kidney cancer and angiomyolipoma in lymphangiomyomatosis] (in German). Urologe A 1994; 33:76-79
72. Brentani MM, Carvalho CR, Saldiva PH, et al. Steroid receptors in pulmonary lymphangiomyomatosis. Chest 1984; 85:96-99
73. Sobonya RE, Quan SF, Fleishman JS. Pulmonary lymphangioleiomyomatosis: quantitative analysis of lesions producing airflow limitation. Hum Pathol 1985; 16:1122-1128
74. Fukuda Y, Kawamoto M, Yamamoto A, et al. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis [see comments]. Hum Pathol 1990; 21:1252-1261
75. Hayashi T, Fleming MV, Stetler-Stevenson WG, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997; 28: 1071-1078
76. Colley MH, Geppert E, Franklin WA. Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis. Am J Surg Pathol 1989; 13:803-807
77. Berger U, Khaghani A, Pomerance A, et al. Pulmonary lymphangioleiomyomatosis and steroid receptors: an immunocytochemical study. Am J Clin Pathol 1990; 93:609-614
78. Bonetti F, Chiodera PL, Pea M, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung: HMB45 for diagnosis [see comments]. Am J Surg Pathol 1993; 17:1092-1102
79. Bacchi CE, Bonetti F, Pea M, et al. HMB-45, a review. Appl Immunohistochem 1996; 42:73-85
80. Guinee DG Jr, Feuerstein I, Koss MN, et al. Pulmonary lymphangioleiomyomatosis: diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high-resolution computed tomography findings. Arch Pathol Lab Med 1994; 118:846-849
81. Chan JKC, Tsang WYW, Pau MY, et al. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993; 22:445-455
82. Hoon V, Thung SN, Kaneko M, et al. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 1994; 118:732-734
83. Pea M, Bonetti F, Zamboni G, et al. Melanocyte marker HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991; 23:185-188
84. Abdulla M, Bui HX, del Rosario AD, et al. Renal angiomyolipoma: DNA content and immunohistochemical study of classic and multicentric variants. Arch Pathol Lab Med 1994; 118:735-739
85. Bjornsson J, Short MP, Kwiatkowski DJ, et al. Tuberous sclerosis-associated renal cell carcinoma: clinical, pathological, and genetic features. 1996; 149:1201-1208
86. Popper HH, Juettner-Smolle FM, Pongratz MG. Micronodular hyperplasia of type II pneumocytes: a new lung lesion associated with tuberous sclerosis. Histopathology 1991; 18:347-354
87. Huml JP, Borkgren MW, Henley LB, et al. Pulmonary lymphangioleiomyomatosis associated with pulmonary parenchymal, hilar, and mediastinal noncaseating granulomas [see comments]. Chest 1991; 100:1726-1728
88. Müller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175:335-339
89. Lenoir S, Grenier P, Brauner MW, et al. Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology 1990; 175:329-334
90. Anonymous. Case Records of the Massachusetts General Hospital (case 24-1988). N Engl J Med 1988; 318:1601-1610
91. Templeton PA, McLoud TC, Muller NL, et al. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 1989; 13:54-57
92. Merchant RN, Pearson MG, Rankin RN, et al. Computerized tomography in the diagnosis of lymphangioleiomyomatosis. Am Rev Respir Dis 1985; 131:295-297
93. Anonymous. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 18-1994: a 37-year-old woman with interstitial lung disease, renal masses, and a previous spontaneous pneumothorax [clinical conference] [see comments] [published erratum appears in N Engl J Med 1995; 332:1455]. N Engl J Med 1994; 330:1300-1306
94. Sherrier RH, Chiles C, Roggli V. Pulmonary lymphangioleiomyomatosis: CT findings [see comments]. AJR Am J Roentgenol 1989; 153:937-940
95. Aberle DR, Hansell DM, Brown K, et al. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology 1990; 176:381-387
96. Shuman RL, Engelman R, Kittle CF. Pulmonary lymphangiomyomatosis. Ann Thorac Surg 1979; 27:70-75
97. Rossi GA, Balbi B, Oddera S, et al. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143:174-176
98. Callol L, Villegas Fernandez FR, Calderon Alvarez J, et al. Pulmonary lymphangiomyomatosis and kidney angiomyolipomas [letter]. Respiration 1993; 60:311
99. Lieberman J, Agliozzo CM. Intrapleural nitrogen mustard for treating chylous effusion of pulmonary lymphangioleiomyomatosis. Cancer 1974; 33:1505-1511
100. King MA. MR diagnosis of lymphangioleiomyomatosis: visibility of pulmonary cysts on spin-echo images. Magn Reson Imaging, 1996; 14:361-363
101. Burger CD, Hyatt RE, Staats BA. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143: 1030-1033
102. Crausman RS, Jennings CA, Mortenson RL, et al. Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity. Am J Respir Crit Care Med 1996; 153: 1368-1376
103. Itami M, Teshima S, Asakuma Y, et al. Pulmonary lymphangiomyomatosis diagnosed by effusion cytology: a case report. Acta Cytol 1997; 41:522-528
104. Tomasian A, Greenberg MS, Rumerman H. Tamoxifen for lymphangioleiomyomatosis [letter]. N Engl J Med 1982; 306:745-746
105. Logan RF, Fawcett IW. Oophorectomy for pulmonary lymphangioleiomyomatosis: a case report. Br J Dis Chest 1985; 79:98-100
106. Estenne M, de Francquen P, Wellens F, et al. Combined heart-and-lung transplantation for lymphangioleiomyomatosis [letter]. Lancet 1984; 1:275
107. Wellens F, Estenne M, de Francquen P, et al. Combined heart-lung transplantation for terminal pulmonary lymphangioleiomyomatosis. J Thorac Cardiovasc Surg 1985; 89:872-876
108. Sawicka EH, Morris AJ. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy. Br J Dis Chest 1985; 79:400-406
109. Lizotte PE, Whitlock WL, Prudhomme JC, et al. Lymphangiomyomatosis. Chest 1990; 98:1044-1045
110. de la Fuente J, Paramo C, Roman F, et al. Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone-releasing hormone analogues [letter]. Eur J Med 1993; 2:377-378
111. Clemm C, Jehn U, Wolf-Hornung B, et al. Lymphangiomyomatosis: a report of three cases treated with tamoxifen. Klin Wochenschr 1987; 65:391-393
112. Klein M, Krieger O, Ruckser R, et al. Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen - a case report. Arch Gynecol Obstet 1992; 252:99-102
113. Eysvogel MMM, Page PS. Lymphangiomyomatosis. Chest 1990; 98:1045-1046
114. Desurmont S, Bauters C, Copin MC, et al. Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist (see comments). Rev Mal Respir 1996; 13:300-304
115. Luna CM, Gene R, Jolly EC, et al. Pulmonary lymphangiomyomatosis associated with tuberous sclerosis: treatment with tamoxifen and tetracycline-pleurodesis. Chest 1985; 88:473-475
116. Fuleihan GE-H. Tissue-specific estrogens - the promise for the future. N Engl J Med 1997; 337:1686-1687
117. Enterline HT, Roberts B. Lymphangiopericytoma: case report of a previously undescribed tumor type. Cancer 1955; 8:582-587
118. Boehler A, Speich R, Russi EW, et al. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335: 1275-1280
119. Nine JS, Yousem SA, Paradis IL, et al. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 1994; 13:714-719
120. O'Brien JD, Lium JH, Parosa JF, et al. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 1995; 151:2033-2036
121. Beck GJ, Sullivan EJ, Stoller JK, et al. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997; 155:670
122. Kalassian KG, Doyle R, Kao P, et al. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997; 155:1183-1186
123. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75:1305-1315
124. Smolarek TA, Wessner LL, McCormack FX, et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998; 62:810-815